NEOMYCIN Drug Patent Profile

Which patents cover Neomycin, and when can generic versions of Neomycin launch?

Neomycin is a drug marketed by Pharmafair, Watson Labs, Xgen Pharms, Bausch And Lomb, Padagis Us, Sciegen Pharms Inc, Alcon Pharms Ltd, Ipharm, Nordic Pharma, Amring Pharms, Sandoz, Adrastea Pharma, Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Nostrum Labs Inc, Roxane, Teva, Fougera, and Pharmaderm. and is included in forty-two NDAs.

The generic ingredient in NEOMYCIN is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.

Summary for NEOMYCIN

US Patents:	0
Applicants:	21
NDAs:	42
Drug Prices:	Drug price information for NEOMYCIN
DailyMed Link:	NEOMYCIN at DailyMed

See drug prices for NEOMYCIN

US Patents and Regulatory Information for NEOMYCIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmaderm	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	neomycin sulfate; triamcinolone acetonide	OINTMENT;TOPICAL	062607-001	May 23, 1986		DISCN	No	No
Bausch And Lomb	NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate; neomycin sulfate	SOLUTION/DROPS;OPHTHALMIC	064055-001	Oct 30, 1995		DISCN	No	No
Nostrum Labs Inc	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	065468-001	Mar 29, 2010		DISCN	No	No
Pharmafair	NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN	gramicidin; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OPHTHALMIC	062383-001	Aug 31, 1982		DISCN	No	No
Roxane	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	062173-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmafair	NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE	bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate	OINTMENT;TOPICAL	062381-001	Sep 6, 1985		DISCN	No	No